New Key Statistics Module, Z-Score and F-Score
OTCPK:ORPOF Key Ratios
| Market Cap $ M | 79.06 |
| Enterprise Value $ M | 93.86 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 105.48 |
| Price/Book | 2.22 |
| Price/Sales | 23.29 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 3.00 |
| EPS (TTM) $ | -1.99 |
| Beneish M-Score | -7.05 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -177.90 |
| EV-to-EBIT | -2.33 |
| EV-to-EBITDA | -2.57 |
| PEG | -- |
| Shares Outstanding M | 24.73 |
| Net Margin (%) | -1,439.06 |
| Operating Margin % | -1,396.26 |
| Pre-tax Margin (%) | -1,428.56 |
| Quick Ratio | 1.28 |
| Current Ratio | 1.28 |
| ROA % (ttm) | -36.83 |
| ROE % (ttm) | -79.53 |
| ROIC % (ttm) | -54.61 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.18 |
ORPOF Number of Guru Trades
ORPOF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ORPOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ORPOF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OSE Immunotherapeutics SA Insider Transactions
No Available Data
News about OTCPK:ORPOF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers